Calcium Sulfate Spacer in Open Tibia Fractures
Phase 4
Terminated
- Conditions
- Open tíbia Fracture With Sub-segmental Bone Loss
- Interventions
- Registration Number
- NCT03042546
- Lead Sponsor
- University of Washington
- Brief Summary
Investigators will compare antibiotic impregnated Calcium sulfate versus PMMA versus nothing in these sub-segmental bone defects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
Inclusion Criteria
- Open tibia shaft fracture treated with an IMN
Exclusion Criteria
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Nothing No treatment - PMMA PMMA - Calcium Sulphate Calcium Sulfate -
- Primary Outcome Measures
Name Time Method Number of Patients With a Nonunion One Year Radiographic healing at one year with no additional surgery
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the antibiotic release profile of calcium sulfate in open tibia fractures?
How does calcium sulfate compare to PMMA as a bone void filler in sub-segmental tibial defects?
Are there specific biomarkers that predict successful bone regeneration with calcium sulfate spacers?
What are the long-term complication rates of antibiotic-impregnated spacers in tibial nonunions?
How do alternative bone graft substitutes like hydroxyapatite compare to calcium sulfate in open fracture management?
Trial Locations
- Locations (1)
Harborview Medical Center
🇺🇸Seattle, Washington, United States
Harborview Medical Center🇺🇸Seattle, Washington, United States